Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunity

Brain Research

Volumn 1379, Issue , 2011, Pages 188-198

  Rocca, Walter A ^a   Grossardt, Brandon R ^b   Shuster, Lynne T ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Cognitive impairment; Dementia; Estrogen; Menopause; Oophorectomy; Window of opportunity hypothesis

Indexed keywords

ESTROGEN; GESTAGEN;

BRAIN; CELL LEVEL; COGNITION; DEMENTIA; DRUG EFFECT; ESTROGEN THERAPY; EXPERIMENTAL STUDY; GENETIC VARIABILITY; HUMAN; HYSTERECTOMY; MENOPAUSE; MENTAL DETERIORATION; NEUROPROTECTION; NONHUMAN; OBSERVATIONAL STUDY; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGING; ANIMALS; COGNITION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; OVARIECTOMY; TIME FACTORS;

ANIMALIA;

EID: 79952311053     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.031     Document Type: Review

References (83)

1. Allison, M.A., Manson, J.E., Aragaki, A., Langer, R.D., Rossouw, J., Curb, D., Martin, L.W., Phillips, L., Stefanick, M.L., Cochrane, B.B., Sarto, G., Barnhart, J., O'Sullivan, M.J., Johnson, K.C., Gass, M., Trevisan, M., Woods, N.F., 2010. Vasomotor symptoms and coronary artery calciumin postmenopausal women. Menopause 17 Epub ahead of print.
2. American College of Obstetricians and Gynecologists, 2008. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. Obstet. Gynecol. 111, 231-241.
3. Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B.V., Hsia, J., Hubbell, A., Jackson, R., Johnson, K.C., Judd, H., Kotchen, J.M., Kuller, L., LaCroix, A.Z., Lane, D., Langer, R.D., Lasser, N., Lewis, C.E., Manson, J., Margolis, K., Ockene, J., O'Sullivan, M.J., Phillips, L., Prentice, R.L., Ritenbaugh, C., Robbins, J., Rossouw, J.E., Sarto, G., Stefanick, M.L., Van Horn, L., Wactawski-Wende, J., Wallace, R., Wassertheil-Smoller, S., 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712. (Pubitemid 38489892)
4. Armstrong, K., Schwartz, J.S., Randall, T., Rubin, S.C., Weber, B., 2004. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J. Clin. Oncol. 22, 1045-1054.
5. Banks, E., Canfell, K., 2009. Invited commentary: hormone therapy risks and benefits - the Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am. J. Epidemiol. 170, 24-28.
6. Brinton, R.D., 2008. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 31, 529-537.
7. Buist, D.S., Newton, K.M., Miglioretti, D.L., Beverly, K., Connelly, M.T., Andrade, S., Hartsfield, C.L., Wei, F., Chan, K.A., Kessler, L., 2004. Hormone therapy prescribing patterns in the United States. Obstet. Gynecol. 104, 1042-1050.
8. Casadesus, G., Webber, K.M., Atwood, C.S., Pappolla, M.A., Perry, G., Bowen, R.L., Smith, M.A., 2006. Luteinizing hormone modulates cognition and amyloid-[beta] deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta 1762, 447-452.
9. Casadesus, G., Milliken, E.L., Webber, K.M., Bowen, R.L., Lei, Z., Rao, C.V., Perry, G., Keri, R.A., Smith, M.A., 2007. Increases in luteinizing hormone are associated with declines in cognitive performance. Mol. Cell. Endocrinol. 269, 107-111.
10. Cramer, D.W., Petterson, K.S., Barbieri, R.L., Huhtaniemi, I.T., 2000. Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum. Reprod. 15, 2103-2107.
11. Di, W., Guo, S.W., 2007. The search for genetic variants predisposing women to endometriosis. Curr. Opin. Obstet. Gynecol. 19, 395-401.
12. Espeland, M.A., Rapp, S.R., Shumaker, S.A., Brunner, R., Manson, J.E., Sherwin, B.B., Hsia, J., Margolis, K.L., Hogan, P.E., Wallace, R., Dailey, M., Freeman, R., Hays, J., 2004. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2959-2968. (Pubitemid 38802685)
13. Farquhar, C.M., Sadler, L., Harvey, S.A., Stewart, A.W., 2005. The association of hysterectomy and menopause: a prospective cohort study. BJOG 112, 956-962. (Pubitemid 40896964)
14. Gibbs, R.B., 2010. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 31, 224-253.
15. Gibbs, R.B., Aggarwal, P., 1998. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm. Behav. 34, 98-111.
16. Grodstein, F., Manson, J.E., Stampfer, M.J., 2006. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J. Womens Health 15, 35-44. (Pubitemid 43192860)
17. Haas, J.S., Kaplan, C.P., Gerstenberger, E.P., Kerlikowske, K., 2004. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann. Intern. Med. 140, 184-188.
18. Hao, J., Janssen, W.G., Tang, Y., Roberts, J.A., McKay, H., Lasley, B., Allen, P.B., Greengard, P., Rapp, P.R., Kordower, J.H., Hof, P.R., Morrison, J.H., 2003. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J. Comp. Neurol. 465, 540-550.
19. Harman, S.M., Brinton, E.A., Cedars, M., Lobo, R., Manson, J.E., Merriam, G.R., Miller, V.M., Naftolin, F., Santoro, N., 2005. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 8, 3-12. (Pubitemid 40675116)
20. Henderson, V.W., Brinton, R.D., 2010. Menopause andmitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog. Brain Res. 182, 77-96.
21. Hersh, A.L., Stefanick, M.L., Stafford, R.S., 2004. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291, 47-53. (Pubitemid 38040534)
22. Hogervorst, E., Bandelow, S., 2007. Should surgical menopausal women be treated with estrogens to decrease the risk of dementia? Neurology 69, 1070-1071.
23. Hogervorst, E., Bandelow, S., 2010. Sex steroids tomaintain cognitive function in women after the menopause: a meta-analyses of treatment trials. Maturitas 66, 56-71.
24. Hogervorst, E., Williams, J., Budge, M., Riedel, W., Jolles, J., 2000. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101, 485-512.
25. Hsia, J., Langer, R.D., Manson, J.E., Kuller, L., Johnson, K.C., Hendrix, S.L., Pettinger, M., Heckbert, S.R., Greep, N., Crawford, S., Eaton, C.B., Kostis, J.B., Caralis, P., Prentice, R., 2006. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch. Intern. Med. 166, 357-365.
26. Huang, J., Guan, H., Booze, R.M., Eckman, C.B., Hersh, L.B., 2004. Estrogen regulates neprilysin activity in rat brain. Neurosci. Lett. 367, 85-87.
27. LeBlanc, E.S., Janowsky, J., Chan, B.K., Nelson, H.D., 2001. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285, 1489-1499. (Pubitemid 32221898)
28. Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., Yaffe, K., 2008. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. CD003122.
29. Luckhaus, C., Sand, P.G., 2007. Estrogen Receptor 1 gene (ESR1) variants in Alzheimer's disease. Results of a meta-analysis. Aging Clin. Exp. Res. 19, 165-168.
30. Manson, J.E., Bassuk, S.S., 2007. Invited commentary: hormone therapy and risk of coronary heart disease - why renew the focus on the early years of menopause? Am. J. Epidemiol. 166, 511-517. (Pubitemid 47283647)
31. Manson, J.E., Bassuk, S.S., Harman, S.M., Brinton, E.A., Cedars, M.I., Lobo, R., Merriam, G.R., Miller, V.M., Naftolin, F., Santoro, N., 2006. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause 13, 139-147.
32. Manson, J.E., Allison, M.A., Rossouw, J.E., Carr, J.J., Langer, R.D., Hsia, J., Kuller, L.H., Cochrane, B.B., Hunt, J.R., Ludlam, S.E., Pettinger, M.B., Gass, M., Margolis, K.L., Nathan, L., Ockene, J.K., Prentice, R.L., Robbins, J., Stefanick, M.L., WHI and WHI-CACS Investigators, 2007. Estrogen therapy and coronary-artery calcification. N Engl J. Med. 356, 2591-2602.
33. Markowska, A.L., Savonenko, A.V., 2002. Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J. Neurosci. 22, 10985-10995. (Pubitemid 36005175)
34. McEwen, B.S., Alves, S.E., 1999. Estrogen actions in the central nervous system. Endocr. Rev. 20, 279-307.
35. Mendelsohn, M.E., Karas, R.H., 1999. The protective effects of estrogen on the cardiovascular system. N Engl J. Med. 340, 1801-1811.
36. Mendelsohn, M.E., Karas, R.H., 2005. Molecular and cellular basis of cardiovascular gender differences. Science 308, 1583-1587. (Pubitemid 40807497)
37. Mendelsohn, M.E., Karas, R.H., 2007. HRT and the young at heart. N Engl J. Med. 356, 2639-2641.
38. Monk, D., Brodaty, H., 2000. Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 11, 1-10.
39. Montgomery, G.W., Nyholt, D.R., Zhao, Z.Z., Treloar, S.A., Painter, J.N., Missmer, S.A., Kennedy, S.H., Zondervan, K.T., 2008. The search for genes contributing to endometriosis risk. Hum. Reprod. Update 14, 447-457.
40. Morrison, J.H., Brinton, R.D., Schmidt, P.J., Gore, A.C., 2006. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J. Neurosci. 26, 10332-10348. (Pubitemid 44564581)
41. Nejat, E.J., Chervenak, J.L., 2010. The continuum of ovarian aging and clinicopathologies associated with the menopausal transition. Maturitas 66, 187-190.
42. Parascandola, M., 2004. Two approaches to etiology: the debate over smoking and lung cancer in the 1950 s. Endeavour 28, 81-86. (Pubitemid 38729855)
43. Parker, W.H., Jacoby, V., Shoupe, D., Rocca, W., 2009. Effect of bilateral oophorectomy on women's long-term health. Womens Health Lond Engl. 5, 565-576.
44. Petitti, D.B., Crooks, V.C., Chiu, V., Buckwalter, J.G., Chui, H.C., 2008. Incidence of dementia in long-term hormone users. Am. J. Epidemiol. 167, 692-700.
45. Phillips, S.M., Sherwin, B.B., 1992. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17, 485-495. (Pubitemid 23015018)
46. Phung, T.K., Waltoft, B.L., Laursen, T.M., Settnes, A., Kessing, L.V., Mortensen, P.B., Waldemar, G., 2010. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement. Geriatr. Cogn. Disord. 30, 43-50.
47. Porrello, E., Monti, M.C., Sinforiani, E., Cairati, M., Guaita, A., Montomoli, C., Govoni, S., Racchi, M., 2006. Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur. J. Neurol. 13, 639-644.
48. Porta, M.S., International Epidemiological Association, 2008. A Dictionary of Epidemiology. Oxford University Press, Oxford; New York.
49. Prentice, R.L., Manson, J.E., Langer, R.D., Anderson, G.L., Pettinger, M., Jackson, R.D., Johnson, K.C., Kuller, L.H., Lane, D.S., Wactawski-Wende, J., Brzyski, R., Allison, M., Ockene, J., Sarto, G., Rossouw, J.E., 2009. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am. J. Epidemiol. 170, 12-23.
50. Rapp, P.R., Morrison, J.H., Roberts, J.A., 2003a. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J. Neurosci. 23, 5708-5714. (Pubitemid 36807849)
51. Rapp, S.R., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E., Gass, M.L., Stefanick, M.L., Lane, D.S., Hays, J., Johnson, K.C., Coker, L.H., Dailey, M., Bowen, D., 2003b. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289, 2663-2672. (Pubitemid 37430137)
52. Renoux, C., Dell'Aniello, S., Garbe, E., Suissa, S., 2010. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 340, c2519.
53. Roberts, R.O., Cha, R.H., Knopman, D.S., Petersen, R.C., Rocca, W.A., 2006. Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings. Alzheimer Dis. Assoc. Disord. 20, 141-146.
54. Rocca, W.A., Bower, J.H., Maraganore, D.M., Ahlskog, J.E., Grossardt, B.R., de Andrade, M., Melton 3rd, L.J., 2007. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69, 1074-1083. (Pubitemid 47517552)
55. Rocca, W.A., Grossardt, B.R., Maraganore, D.M., 2008. The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener. Dis. 5, 257-260.
56. Rocca, W.A., Shuster, L.T., Grossardt, B.R., Maraganore, D.M., Gostout, B.S., Geda, Y.E., Melton 3rd, L.J., 2009. Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Womens Health Lond Engl. 5, 39-48.
57. Rocca, W.A., Grossardt, B.R., Shuster, L.T., 2010. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener. Dis. 7, 163-166.
58. Rodrigues, M.A., Verdile, G., Foster, J.K., Hogervorst, E., Joesbury, K., Dhaliwal, S., Corder, E.H., Laws, S.M., Hone, E., Prince, R., Devine, A., Mehta, P., Beilby, J., Atwood, C.S., Martins, R.N., 2008. Gonadotropins and cognition in older women. J. Alzheimers Dis. 13, 267-274. (Pubitemid 352039028)
59. Rossouw, J.E., Prentice, R.L., Manson, J.E., Wu, L., Barad, D., Barnabei, V.M., Ko, M., LaCroix, A.Z., Margolis, K.L., Stefanick, M.L., 2007. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297, 1465-1477. (Pubitemid 46556472)
60. Salpeter, S.R., Cheng, J., Thabane, L., Buckley, N.S., Salpeter, E.E., 2009. Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am. J. Med. 122, 1016-1022 e1011.
61. Schwartz, S., Carpenter, K.M., 1999. The right answer for the wrong question: consequences of type III error for public health research. Am. J. Public Health 89, 1175-1180. (Pubitemid 29359569)
62. Sherwin, B.B., 1988. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13, 345-357.
63. Sherwin, B.B., Phillips, S.J., 1990. Estrogen and cognitive functioning in surgically menopausal women. Ann. NY Acad. Sci. 592, 474-475.
64. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., Hendrix, S.L., Jones 3rd, B.N., Assaf, A.R., Jackson, R.D., Kotchen, J.M., Wassertheil-Smoller, S., Wactawski-Wende, J., 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289, 2651-2662. (Pubitemid 37430136)
65. Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S., Fillit, H., Stefanick, M.L., Hendrix, S.L., Lewis, C.E., Masaki, K., Coker, L.H., 2004. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2947-2958. (Pubitemid 38802684)
66. Shuster, L.T., Gostout, B.S., Grossardt, B.R., Rocca, W.A., 2008. Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int. 14, 111-116.
67. Shuster, L.T., Rhodes, D.J., Gostout, B.S., Grossardt, B.R., Rocca, W.A., 2010. Premature menopause or early menopause: long-term health consequences. Maturitas 65, 161-166.
68. Siegfried, T., 2007. Neuroscience: it's all in the timing. Nature 445, 359-361. (Pubitemid 46160889)
69. Snieder, H., MacGregor, A.J., Spector, T.D., 1998. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J. Clin. Endocrinol. Metab. 83, 1875-1880.
70. Snowdon, D.A., Kane, R.L., Beeson, W.L., Burke, G.L., Sprafka, J.M., Potter, J., Iso, H., Jacobs Jr., D.R., Phillips, R.L., 1989. Is early natural menopause a biologic marker of health and aging? Am. J. Public Health 79, 709-714. (Pubitemid 19142908)
71. Sommer, A., 2009. Getting What We Deserve: Health and Medical Care in America. Johns Hopkins University Press, Baltimore.
72. Szklo, M., Nieto, F.J., 2007. Epidemiology: Beyond the Basics. Jones and Bartlett Publishers, Sudbury, MA.
73. Tang, Y., Janssen, W.G., Hao, J., Roberts, J.A., McKay, H., Lasley, B., Allen, P.B., Greengard, P., Rapp, P.R., Kordower, J.H., Hof, P.R., Morrison, J.H., 2004. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb. Cortex 14, 215-223. (Pubitemid 38141537)
74. Toh, S., Hernandez-Diaz, S., Logan, R., Rossouw, J.E., Hernan, M.A., 2010. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann. Intern. Med. 152, 211-217.
75. Umetani, M., Domoto, H., Gormley, A.K., Yuhanna, I.S., Cummins, C.L., Javitt, N.B., Korach, K.S., Shaul, P.W., Mangelsdorf, D.J., 2007. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13, 1185-1192.
76. Utian, W.H., 2001. Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause 8, 398-401. (Pubitemid 33111574)
77. Vujovic, S., Brincat, M., Erel, T., Gambacciani, M., Lambrinoudaki, I., Moen, M.H., Schenck-Gustafsson, K., Tremollieres, F., Rozenberg, S., Rees, M., 2010. EMAS position statement: managing women with premature ovarian failure. Maturitas 67, 91-93.
78. Waring, S.C., Rocca, W.A., Petersen, R.C., O'Brien, P.C., Tangalos, E.G., Kokmen, E., 1999. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52, 965-970. (Pubitemid 29161604)
79. Webber, K.M., Casadesus, G., Marlatt, M.W., Perry, G., Hamlin, C.R., Atwood, C.S., Bowen, R.L., Smith, M.A., 2005. Estrogen bows to a newmaster: the role of gonadotropins in Alzheimer pathogenesis. Ann. NY Acad. Sci. 1052, 201-209.
80. Weel, A.E., Uitterlinden, A.G., Westendorp, I.C., Burger, H., Schuit, S.C., Hofman, A., Helmerhorst, T.J., van Leeuwen, J.P., Pols, H.A., 1999. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J. Clin. Endocrinol. Metab. 84, 3146-3150.
81. Writing Group for the Women's Health Initiative, I., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288, 321-333.
82. Yaffe, K., Sawaya, G., Lieberburg, I., Grady, D., 1998. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279, 688-695. (Pubitemid 28138739)
83. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C., Breitner, J.C., 2002. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288, 2123-2129. (Pubitemid 35265379)